TP53 and acute myeloid leukemia: In line with our bulk RNA sequencing results, chemotherapy-induced inflammatory and senescence-associated responses mainly driven by TNF/NFKB and interferon signaling, along with p53, UV and DNA repair pathway activation across most AML clusters (Fig. 5G, H).